A Study of Tislelizumab in Combination With Investigational Agents in Participants With Non-Small Cell Lung Cancer (BGB-LC-201)
Beacon Hospital Sdn Bhd
PRINCIPAL INVESTIGATOR
Dr Azura Rozila Ahmad
drazura@beaconhospital.com.my
03-77860846
A Phase 3, Randomised, Double blind, Placebo controlled, Multicentre, International Study of Durvalumab plus Domvanalimab (AB154) in Participants with Locally Advanced (Stage III), Unresectable Non small Cell Lung Cancer Whose Disease has not Progressed Following Definitive Platinum based Concurrent Chemoradiation Therapy (PACIFIC-8)
Phase III, Stage III, Received concurent chemradiation with no progression, PD-L1 positive
University of Malaya Medical Centre (UMMC)
PRINCIPAL INVESTIGATOR
Prof Adlinda
adlinda@ummc.edu.my
CONTACT
SC: Alice 03-79492120 (Research Room)
Beacon Hospital Sdn Bhd
PRINCIPAL INVESTIGATOR
Dato’ Dr Mohamed Ibrahim A Wahid
dribrahim@beaconhospital.com.my
+603-77872830
Hospital Sultan Ismail
PRINCIPAL INVESTIGATOR
DR LIM CHUN SEN
chunsen1@hotmail.com
CONTACT
SC: Narmatha Gurumoorthy, Farah Nadia Binti Mohd Hashim
Sarawak General Hospital
PRINCIPAL INVESTIGATOR
DR VOON PEI JYE
voonpj@yahoo.com
CONTACT
SC: Anna Ting Huong Juan
Pantai Hospital Kuala Lumpur
PRINCIPAL INVESTIGATOR
DR JOHN LOW SENG HOOI
john.low@pantaidr.my
CONTACT
SC: AINI RASIDDA NORAZMI
Open-label Phase 3 Study of MK-7684A (Coformulation of Vibostolimab With Pembrolizumab) in Combination With Concurrent Chemoradiotherapy Followed by MK-7684A Versus Concurrent Chemoradiotherapy Followed by Durvalumab in Participants With Unresectable, Locally Advanced, Stage III NSCLC (MK-7684A-006/KEYVIBE-006)
Phase III, Stage IIIA; IIIB; IIIC, No prior treatment (chemotheraphy, radiotherapy & immunotherapy) for Stage III
University of Malaya Medical Centre (UMMC)
PRINCIPAL INVESTIGATOR
Dr Ho Gwo Fuang
fuang@ummc.edu.my
CONTACT
SC: Kimee 03-79492120 (Research Room)
Hospital Pulau Pinang
PRINCIPAL INVESTIGATOR
TAN AI LIAN
CONTACT
Dhinesweri
General line: 04-2225 333
CRC: 042225 767 / 2225 762 / 2225 766 / 2225 586
Dr. Yoon Chee Kin, Ketua Jabatan
dryoonck@moh.gov.my (email)
Sister Zarina Bt Che Umar, Admin Manager
zarinacu@gmail.com (Email)
Kuala Lumpur Hospital (HKL)
PRINCIPAL INVESTIGATOR
Dr Sandya Subramaniam
CONTACT
General line: 03 – 2615 5555
CRC: 03 – 2615 5555 Ext. 6262 (Tel)
crc.hkl@moh.gov.my (email)
Crc Hkl / Clinical Research Centre HKL (Facebook)